HK Stock MarketDetailed Quotes

CHINARES PHARMA (03320)

Watchlist
  • 6.270
  • +0.120+1.95%
Market Closed Apr 2 16:07 CST
39.39BMarket Cap8.79P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CHINARES PHARMA (03320) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Distribution division212.06B78.66%
Manufacturing branch45.21B16.77%
Retail branch12.21B4.53%
Other93.25M0.03%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Distribution division212.06B78.66%
Manufacturing branch45.21B16.77%
Retail branch12.21B4.53%
Other93.25M0.03%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
China Mainland131.34B99.60%
中国香港及其他522.28M0.40%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +4.97%
Sample Name
Sample Code
 +0.60%
Sample Name
Sample Code
 -8.31%
4
SINOPEC CORP
00386
-11.73%
5
SINO OIL & GAS
00702
-12.82%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.50%
Sample Name
Sample Code
 +17.32%
Sample Name
Sample Code
 +12.02%
4
Ucloud Technology Co., Ltd
688158
+9.99%
5
Hangzhou Shunwang Technology
300113
+8.95%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -